Angiotensin II receptor blocker improves the lowered exercise capacity and impaired mitochondrial function of the skeletal muscle in type 2 diabetic mice. J Appl Physiol 114: 844 -857, 2013. First published January 17, 2013 doi:10.1152/japplphysiol.00053.2012.-NAD(P)H oxidase-induced oxidative stress is at least in part involved with lowered exercise capacity and impaired mitochondrial function in high-fat diet (HFD)-induced diabetic mice. NAD(P)H oxidase can be activated by activation of the renin-angiotensin system. We investigated whether ANG II receptor blocker can improve exercise capacity in diabetic mice. C57BL/6J mice were fed a normal diet (ND) or HFD, and each group of mice was divided into two groups: treatment with or without olmesartan (OLM; 3 mg·kg Ϫ1 ·day Ϫ1 in the drinking water). The following groups of mice were studied: ND, NDϩOLM, HFD, and HFDϩOLM (n ϭ 10 for each group). After 8 wk, HFD significantly increased body weight, plasma glucose, and insulin compared with ND, and OLM did not affect these parameters in either group. Exercise capacity, as determined by treadmill tests, was significantly reduced in HFD, and this reduction was ameliorated in HFDϩOLM. ADP-dependent mitochondrial respiration was significantly decreased, and NAD(P)H oxidase activity and superoxide production by lucigenin chemiluminescence were significantly increased in skeletal muscle from HFD, which were attenuated by OLM. There were no such effects by OLM in ND. We concluded that OLM ameliorated the decrease in exercise capacity in diabetic mice via improvement in mitochondrial function and attenuation of oxidative stress in skeletal muscle. These data may have a clinical impact on exercise capacity in the medical treatment of diabetes mellitus. oxidative stress; angiotensin; diabetes; mitochondria; muscle EXERCISE CAPACITY IS LOWERED in patients with metabolic syndrome and type 2 diabetes (30, 42), which is an independent predictor for mortality (37). The first line in the prevention and treatment of diabetes is lifestyle intervention including physical exercise and diet. However, the lowered exercise capacity might prevent the completion of proper and endurance exercise in patients with type 2 diabetes. To date, pharmacological intervention to specifically improve exercise capacity has not been elucidated.
Moreover, mitochondrial function was impaired in skeletal muscle from patients with type 2 diabetes (22) . We previously reported that exercise capacity was lowered and mitochondrial function was impaired in the skeletal muscle from high-fat diet (HFD)-induced type 2 diabetic mice, which was due to enhanced oxidative stress via the activation of NAD(P)H oxidase (41) . The NAD(P)H oxidase-induced enhancement of oxidative stress was also demonstrated in skeletal muscle from patients with type 2 diabetes (31) . However, the mechanism for activation of NAD(P)H oxidase has not been determined. NAD(P)H oxidase activity can be increased by high glucose, insulin, and fatty acid as well as activation of the reninangiotensin system (RAS) (39) . RAS has been shown to be activated in the skeletal muscle of fructose-fed diabetic rats (23) . Therefore, the activation of RAS may play an important role also in NAD(P)H oxidase and impaired mitochondrial function, leading to the lowered exercise capacity in HFDinduced type 2 diabetic mice. We thus hypothesized that the ANG II type 1 receptor (AT1R) blocker, olmesartan (OLM), could ameliorate the enhanced oxidative stress and lowered exercise capacity in these mice.
The purpose of the present study was to determine whether 1) RAS is activated in whole body and/or in skeletal muscle from HFD-induced diabetic mice and 2) the administration of OLM in these mice can ameliorate impaired mitochondrial function and lowered exercise capacity.
MATERIALS AND METHODS
Experimental animals. Male C57BL/6J mice (10 -12 wk of age) were housed in an animal room under controlled conditions on a 12:12-h light-dark cycle. Mice were fed for 8 wk on either normal diet (ND; CE-2; CLEA Japan, Tokyo, Japan) containing 4.2% fat and 54.6% carbohydrate or HFD (HFD32; CLEA Japan) containing 32.0% fat and 29.4% carbohydrate. Mice were divided into two groups with or without OLM (3 mg·kg Ϫ1 ·day Ϫ1 ) in the drinking water, including 0.1% NaHCO 3-0.1% KHCO3. The quantities of water consumed by each mouse, as well as body weight, were monitored every week, and the dose of OLM in drinking water was adjusted. We estimated the dose of OLM consumed by mice, which was in the range of 3.0 -3.2 mg·kg Ϫ1 ·day Ϫ1 . The concentration of OLM in the present study was chosen on the basis of previous studies (33, 43) . The present study was performed in the following four groups of mice: 1) ND (n ϭ 10), 2) NDϩOLM (n ϭ 10), 3) HFD (n ϭ 10), and 4) HFDϩOLM (n ϭ 10). These assignment procedures were performed using numeric codes to identity the animals. All procedures and animal care were approved by our institutional animal research committee and conformed to the animal care guidelines for the Care and Use of Laboratory Animals at Hokkaido University Graduate School of Medicine.
Eight weeks after treatment, exercise tests and intraperitoneal glucose tolerance tests were performed. After that, blood samples were collected, all mice were euthanized, and organ weight was measured. Because the amount of hindlimb skeletal muscle samples was limited, they were divided for use in the experiments for mitochondrial O 2 consumption (n ϭ 15), and the biochemical assay including superoxide (O 2 Ϫ ) production (n ϭ 7) and NAD(P)H oxidase activity (n ϭ 9).
Blood pressure measurements. Systemic blood pressure was measured using the tail-cuff method (BP-98A; Softron, Tokyo, Japan) without anesthesia.
Biochemical measurement and organ weight. After the animals had fasted for 6 h, blood samples were collected from the inferior vena cava before euthanizing under deep anesthesia with tribromoethanolamylene hydrate (Avertin; 2.5% wt/vol, 10 l/g ip). Plasma insulin levels were measured by ELISA kit (Morinaga Institute of Biochemical Science, Yokohama, Japan). Total cholesterol, triglyceride, and nonesterified fatty acid (NEFA) were measured by using the Cholesterol E-test, Triglyceride E-test, and NEFA C-test, respectively (Wako Pure Chemical Industries, Osaka, Japan). Plasma renin activity levels were measured using a SensoLyte 520 Renin Assay Kit (AnaSpec, San Jose, CA). Serum angiotensin-converting enzyme (ACE) activity levels were measured in a fluorescence assay using an ACE activity assay kit (Life Laboratory, Yamagata, Japan). Plasma ANG II levels were measured using an EIA kit (Peninsula Laboratories, San Carlos, CA). Serum aldosterone levels were measured using an ELISA kit (Endocrine Technologies, Newark, CA). Serum ␤-hydroxybutyrate (␤-OHB) levels were measured using a commercially available kit (Abcam, Cambridge, MA). Heart, epididymal fat, and unilateral hindlimb skeletal muscle were then excised and weighed. Total hindlimb skeletal muscle was used in all experiments except for fiber type staining.
Intraperitoneal glucose and insulin tolerance test. For glucose or insulin tolerance tests, mice were fasted for 6 h and were given an intraperitoneal injection of glucose (1 mg/g) or human regular insulin (0.5 mU/g) in purified water. Blood samples were repeatedly drawn from the tail vein of the same mice before and 15, 30, 60, 90, and 120 min after the injection. Blood glucose levels were determined using a glucometer (Glutest Ace R; Sanwa Kagaku Kenkyusho, Nagoya, Japan).
Immunoblotting in the skeletal muscle. Immunoblotting was performed as previously described (14, 24) . Hindlimb skeletal muscle tissue samples were homogenized in 1ϫ cell lysis buffer (Cell Signaling, Danvers, MA), supplemented with 1ϫ complete protease inhibitor cocktail (Roche, Basel, Switzerland) and 1 mmol/l phenylmethylsulphonic fluoride. After sonification and centrifugation at 15,000 g for 10 min at 4°C, the supernatants were collected. Protein aliquots were taken for total protein assay (Pierce BCA, Rockford, IL), and the remaining lysate of 20 g was added onto 10% polyacrylamide gels (Bio-Rad, Hercules, CA), electrophoretically separated by SDS-PAGE using running buffer, and transferred by electroblotting to a polyvinylidene fluoride membrane (Bio-Rad) using transfer buffer at 20 V overnight. After the membranes were blocked in Tris-buffered saline buffer with 0.1% Tween-20 (TBST) in 5% non-fat dry milk, they were incubated overnight at 4°C with primary antibodies (dilution 1:1,000) against the phosphorylated forms of AMP-activated protein kinase ␣ (AMPK␣) Thr-172, total AMPK␣, G␣q (Cell Signaling), and AT1R (Santa Cruz Biotechnology, Santa Cruz, CA). After being washed three times in TBST buffer, the membranes were incubated with secondary antibodies conjugated with horseradish peroxidase (dilution 1:5,000; Santa Cruz Biotechnology). The membranes were washed again in TBST and incubated with the chemiluminescence detection reagent in the Amersham ECL Western Blotting Analysis System (GE Healthcare, Chalfont St Giles, United Kingdom) for enhanced chemiluminescence. Equal loading of protein was verified by immunoblotting with GAPDH (Cell Signaling).
Quantitative reverse transcription-polymerase chain reaction. Total RNA was extracted from the hindlimb skeletal muscle in the four groups of mice by using QuickGene-810 (Fujifilm, Tokyo, Japan) according to the manufacturer's instructions. The RNA concentration was measured by photometry at 260 nm (Nanodrop, Peqlab, Erlangen, Germany). RNA purity was determined by measuring the 260/280 and 260/230 absorbance ratios. Purity was also tested and was consistently between a 260/280 absorbance ratio of 1.8 and 2.2 (data not shown).
The extracted total RNA (2 g) was reverse-transcribed to cDNA. cDNA was synthesized with a high capacity cDNA reverse transcription kit (10ϫ reverse transcription 2.0 l, 25ϫ dNTPs 0.8 l, 10ϫ phox (Mm00447921_ml), p67 phox (Mm00-726636_ml), p40 phox (Mm00476300_ml), Rac-1 (Mm01201653_mH), superoxide dismutase 1 (SOD1; Cu/Zn-SOD, Mm01344233_ml), SOD2 (Mn-SOD, Mm01313000_ml), Cat (Mm00437992), and glutathione peroxidase (GPX; Mm00656767_ml). The real-time PCR detection system (Bio-Rad Laboratories) was used with the following conditions: denaturation at 50°C for 2 min, at 95°C for 10 min, followed by 40 cycles of 95°C for 15 s, and at 60°C for 1 min for annealing and extension. Relative mRNA was analyzed with the delta-delta threshold cycle (⌬⌬Ct) method and normalized to GAPDH as the internal control. Each ⌬Ct value was determined by subtracting the GAPDH RNA Ct value from the target gene Ct value. The ⌬⌬Ct value was calculated by subtracting the ⌬Ct value of the ND mice from the ⌬Ct value of the NDϩOLM, HFD, and HFDϩOLM mice. The value 2
Ϫ⌬⌬Ct represented the average relative amount of mRNA for each target gene. There was no difference in the GAPDH mRNA Ct value among the four groups of mice. PCR was performed in duplicate.
Treadmill testing with gas analysis. Mice were treadmill tested to measure indexes defining whole body exercise capacity as previously described with minor modification (16, 41) . At the time of treadmill testing, each mouse was placed on a treadmill enclosed by a metabolic chamber through which air flow of constant speed (1 l/min) is passing (Oxymax 2; Columbus Instruments, Columbus, OH). O 2 and CO2 gas fractions were monitored at both the inlet and output ports of the metabolic chamber. Basal measurements were obtained over a period of 10 min. Mice were then provided with a 10-min warm-up period at 6 m/min at zero degrees. After the animals warmed up, the angle was fixed at 10 degrees and the speed was incrementally increased by 2 m/min every 2 min until the mouse reached exhaustion. Exhaustion was defined as spending time (10 s) on the shocker plate without attempting to reengage the treadmill. Whole body O 2 uptake (V O2) and CO2 production (V CO2) were automatically calculated every 10 s by taking the difference between the inlet and output gas flow. The respiratory exchange ratio was calculated as V CO2 divided by V O2. Work was defined as the product of the vertical running distance to exhaustion and body weight. Blood lactate levels were determined in one drop of blood obtained from tails of mice at rest and at the end of a single bout of exercise by treadmill test. Lactate concentration was assayed using a Lactate Pro-LT portable lactate blood analyzer (Arkray, Kyoto, Japan) according to the manufacturer's instructions.
Spontaneous physical activity. Spontaneous physical activity was measured using an animal movement analysis system (ACTIMO System; Shintechno, Fukuoka, Japan), which consists of a rectangular enclosure (30 ϫ 20 cm), with a sidewall equipped with photosensors at 2-cm intervals (5) . Each pair of photosensors scanned animal movement at 0.5-s intervals. Spontaneous activity was recorded after 8 wk in all groups of mice (n ϭ 8 each). Mice were placed in individual chambers and housed in cages for 1 day before each recording, to become familiarized with the recording environment.
Movement signal counts were performed using the Spike 2 analysis program.
Mitochondrial O 2 consumption in the skeletal muscle. Hindlimb skeletal muscle tissues were quickly harvested, and mitochondria were isolated as previously described (41) . The isolated mitochondrial protein concentration was measured by the BCA protein assay (Pierce, Rockford, IL). O 2 consumption by isolated mitochondria was measured polarographically using an O2 electrode (Yellow Springs Instruments, Yellow Springs, OH) in a closed and magnetically stirred glass chamber at 28°C, as previously described (41) . After a 1-min equilibration period, mitochondrial respiration was initiated by the addition of 2.5 mmol/l L-glutamate and L-malate or 10 mol/l palmitoyl-L-carnitine and 2 mmol/l L-malate as substrates. ADP-stimulated (state 3) respiration was determined after adding ADP (300 mol/l) (22) . The initiation of state 3 was rapidly observed, and concentration of O 2 linearly and sharply declined after the addition of ADP. The cessation of state 3 was also abruptly observed, followed by gentle decline of O2 concentration with a clear inflection point. Non-ADP- stimulated (state 4) respiration was measured in the absence of ADP phosphorylation and validated by oligomycin (2 mg/l), an ATPase inhibitor. An inflection point was objectively determined as an intersection point of two regression lines during 30 s after the addition of ADP and 30 s after the addition of oligomycin. The respiratory control index (RCI) was calculated as the ratio of state 3 to state 4 respiration, and the P/O ratio was calculated as the ratio of amount of ATP to consumed O 2 during state 3. Therefore, RCI indicates overall mitochondrial respiratory activity, and P/O ratio indicates efficiency of ATP synthesis.
Mitochondrial membrane potential. Mitochondrial membrane potential in the skeletal muscle was measured by plate reader using the fluorescent probe 5,5=,6,6=-tetrachloro-1,1=,3,3= tetraethylbenzimidazolylcarbo-cyanine iodide (JC-1; Molecular Probes, Carlsbad, CA). Skeletal muscle cells were loaded with JC-1 for 30 min at 37°C. Samples were excited at 485 nm for monomer fluorescence and 540 nm for JC-1 aggregate fluorescence. Emission fluorescence images were recorded at 560 nm for monomer (green) and 590 nm for JC-1 aggregates (red). The red/green fluorescence ratio was used as an index of changes in membrane potential. Mitochondrial membrane depolarization was indicated by a reduction in the red/green fluorescence intensity ratio. Each experimental group was repeated in duplicate or triplicate wells per plate and averaged to give a single value per experiment.
Histology in skeletal muscle. Hindlimb skeletal muscle was excised, fixed in 4% paraformaldehyde, embedded in paraffin, and stained with hematoxylin-eosin (HE) for histological analysis. Morphological analysis of cell cross-sectional area was performed in at least 50 cells from each mouse (14) .
The methods for staining of fiber type have been described previously (11, 29, 40) . Gastrocnemius was used in fiber type staining because it consists of a variety of fiber type muscle. In brief, physiological metabolic fiber type designation as slow oxidative, fast oxidative glycolytic, and fast glycolytic is based on cytophotometrically quantified activities of myosin ATPase (marker of contractile activity), succinate dehydrogenase (SDH; marker of oxidative activity), and cyclooxygenase (COX; marker of oxidative activity) in serial cross-sections of the same fiber.
Sections were brought to room temperature, air-dried for 30 min, and then stained for ATPase activity following acid (pH 4.51) preincubation. Fiber type classification was performed according to the staining intensities. For determination of ATPase activity, the following procedure was used: preincubation in 50 mmol/l sodium acetate and 30 mmol/l sodium barbital and incubation in 2.8 mmol/l ATP and 50 mmol/l CaCl 2. After they were stained for ATPase activity, sections were processed through 1% CaCl2, 2% CoCl2, and 1% (NH4)2S and dehydrated through a graded series of ethanol followed by two changes in xylene and then coverslipped.
For SDH, the frozen sections were incubated at 37°C for 30 -45 min in a solution containing 1 ml of 0.5 M sodium succinate and 9 ml tetrazolium solution at pH 7. The latter solution contained 2.5 ml nitroblue tetrazolium (2 mg/ml distilled water), 2.5 ml 0.2 M Tris·HCl pH 7.4, 1 ml 0.05 M magnesium chloride, and 3 ml distilled water. Following incubation, the sections were fixed in 15% formol-saline, dehydrated, cleared, and mounted.
COX staining was performed by incubating sections for 1 h in a 50 mM Tris·HCl buffer (pH 7.6) containing 0.22 M sucrose, 14 mM 3,39-diaminobenzidine tetrahydrochloride, 80 mM cytochrome c, and 1,300 units catalase. Sites of COX activity were colored brown.
Pyruvate dehydrogenase enzyme activity. Pyruvate dehydrogenase (PDH) enzyme activity was measured using a PDH enzyme activity microplate assay kit according to manufacturer's instructions (MitoSciences, Eugene, OR). In brief, 10 mg of vastus lateralis muscle was homogenized in 100 l PBS. Sample protein concentration was measured using the Bradford assay before detergent was added to the sample to solubilize intact functional PDH. The samples were then incubated on ice for 10 min before centrifuging at 10,000 g for 10 min at 4°C. Sample supernatant was then diluted with buffer to achieve a dilution of 0.2 g/200 l; 200 l of solubilized, diluted sample was added to each well of the microplate before the microplate was incubated for 3 h prior to washing with a stabilizer. Finally, assay solution was added to the plate. before reading the absorbance of each well at 450 nm using a kinetic program with 60 s between reads (Multiskan Ascent plate reader, Ascent software V 2.6; Thermo Scientific, Loughborough, United Kingdom).
O 2 Ϫ production, NAD(P)H oxidase activity, tiobarbituric acid reactive substances, and antioxidant capacity. The chemiluminescence elicited by O 2 Ϫ in the presence of lucigenin (5 mol/l) was measured in hindlimb skeletal muscle using a luminometer (AccuFLEX Lumi 400; Aloka, Tokyo, Japan) as previously described (41) . To validate that the chemiluminescence signals were derived from O 2 Ϫ , the measurements were also performed in the presence of tiron (20 mmol/l), a cell-permeant, nonenzymatic scavenger of O 2 Ϫ . NAD(P)H oxidase activity was measured in the homogenates isolated from hindlimb skeletal muscle by the lucigenin assay after the addition of NAD(P)H (300 mol/l) as previously described (41) . In separate experiments, the source of O 2 Ϫ production and the role of other enzyme activity for O 2 Ϫ production in isolated skeletal muscle from HFD mice were determined. O 2 Ϫ production was performed in the absence or presence of various inhibitors, such as rotenone (100 mol/l), oxyprinol (100 mol/l), N G -nitro-L-arginine methyl ester (100 mol/l), or apocynin (100 mol/l). Chemiluminescence was also measured in the homogenates isolated from skeletal muscle in HFD mice by the lucigenin assay after the addition of succinate (5 mmol/l), xanthine (100 mol/l), L-arginine (1 mmol/l), or NAD(P)H (100 mol/l) (14) .
The degree of lipid peroxidation in serum and skeletal muscle was determined though biochemical assay of malondialdehyde formation Ϫ is linearly related to xanthine oxidase activity and is inhibited by SOD. The SOD activity was determined by inhibition of the rate of water-soluble formazan formation at 450 nm absorbance.
Cat activities were assayed using the method described in Ref. 20 . The reaction mixture (1 ml) consisted of 50 mM potassium phosphate buffer (pH 7.0), 2 M H 2O2, and a 30-l sample. The reaction was initiated by the addition of H2O2, and absorbance changes were measured at 240 nm (25°C) for 30 s. The molar extinction coefficient for H2O2 is 43.6 M Ϫ1 cm
Ϫ1
. Cat activity was expressed as the unit that is defined as millimoles of H2O2 consumed per minute per gram of wet tissue.
GPX activity was assayed as described in Ref. 20 . The reaction mixtures (1 ml) containing 50 mM potassium phosphate buffer (pH 7.7), 500 mM GSH, 12.5 units GR, 20 mM NADPH, 100 mM NaN3, 50 mM H2O2, and 30-l samples were incubated at 25°C for 5 min. The kinetic change was spectrophotometrically recorded at 340 nm (25°C) for 3 min. The molar extinction coefficient for H2O2 is 66.2 M Ϫ1 cm Ϫ1 . GPX activity was expressed as a unit, which is defined as the unit (mmol oxidized NADPH/min) per gram of wet tissue.
Statistical analysis. Data are expressed as means Ϯ SE. For multiple-group comparisons, two-way ANOVA followed by the Tukey's test was performed. In intraperitoneal glucose and insulin tolerance tests, differences between groups were determined with repeated-measures ANOVA. A value of P Ͻ 0.05 was considered statistically significant.
RESULTS
Animal characteristics. Table 1 shows animal characteristics in four groups of mice. There were no significant differences in systolic blood pressure and heart rate between ND and HFD mice. Systolic blood pressure in HFDϩOLM mice was significantly lower than that in ND mice, but was comparable with that in HFD mice. Heart rate did not change by OLM. Body weight was significantly higher in the HFD mice compared with the ND mice, which was accompanied by the significant increase in epididymal fat weight. There was no difference in the weights of skeletal muscle including quadriceps, gastrocnemius, and soleus between ND and HFD mice. Fasting blood glucose and plasma insulin levels were significantly higher in HFD mice. Total cholesterol and NEFA were also significantly higher in HFD mice, but triglyceride was comparable between ND and HFD mice.
Blood glucose levels during an intraperitoneal glucose and insulin tolerance test were significantly higher in HFD than in ND mice (Fig. 1) . These results showed that HFD feeding for 8 wk induced type 2 diabetes with the characteristics of obesity and glucose intolerance. Importantly, HFDϩOLM mice showed no significant differences from HFD mice in these parameters (Table 1 and Fig. 1 ), indicating that OLM did not affect blood pressure, obesity, and diabetic status in HFD.
Blood and skeletal muscle RAS. There was no difference in plasma renin activity between ND and HFD mice, and OLM increased it (Fig. 2A) . Serum ACE activity and plasma ANG II levels were higher in HFD than in ND mice (Fig. 2, B and C) . OLM significantly increased them in ND mice, and OLM slightly increased them in HFD mice (Fig. 2, B and C) . Serum aldosterone levels were increased in HFD mice compared with ND mice, and significantly decreased in HFDϩOLM mice (Fig. 2D) . We also determined whether RAS in the skeletal muscle was activated. Gene expressions of angiotensinogen, cathepsin D, and ACE were comparable in skeletal muscle among the four groups (Fig. 3, A-C) . There was also no difference in protein levels of AT1R among the four groups (Fig. 3D) . In contrast, protein levels of G␣q were increased in HFD mice compared with ND mice, and significantly decreased in HFDϩOLM mice (Fig. 3E) .
Exercise capacity. Figure 4A shows a representative plot of V O 2 corresponding to each workload during exercise in ND, NDϩOLM, HFD, and HFDϩOLM mice. The work to exhaustion was decreased in HFD compared with ND mice, which was accompanied by a decrease in peak V O 2 . These changes were ameliorated in HFDϩOLM mice. Run time (Fig. 4B ), running distance (Fig. 4C) , and work ( were significantly decreased in HFD compared with ND mice and were significantly improved in HFDϩOLM mice (respectively, P Ͻ 0.05). There was no difference in peak V O 2 and V CO 2 in either group. Coincident with the limited exercise capacity, peak V O 2 and V CO 2 corrected by body weight were significantly decreased in HFD compared with ND mice, and this decrease was ameliorated in HFDϩOLM mice (Table 2) . Peak respiratory exchange ratio values were Ͼ1.0 and did not differ among the four groups of mice, indicating that treadmill tests were performed until exhaustion beyond the anaerobic threshold in all groups of mice. Even after peak V O 2 was corrected by skeletal muscle weight to exclude the influence of the differences in body composition, it was significantly decreased in HFD compared with ND mice and was significantly improved in HFDϩOLM mice ( Table 2) . Lactate level at rest was comparable among groups, and lactate level after exercise was increased compared with rest in all groups (Table 2 ). Lactate level after exercise was significantly increased in HFD mice compared with ND mice and was comparable between HFD and HFDϩOLM mice ( Table  2 ). Lactate level corrected by work was significantly decreased in HFDϩOLM compared with HFD mice (Table 2) .
Spontaneous physical activity. Physical activity was decreased in HFD mice compared with ND mice, and OLM did not affect it in both ND and HFD mice (Fig. 4E) .
Mitochondrial O 2 consumption in skeletal muscle. Figure 5A shows representative recordings of O 2 consumption in mitochondria isolated from hindlimb skeletal muscle measured by O 2 electrodes. RCI was Ͼ3.0 in the isolated mitochondria from all ND mice in the present study, indicating that the mitochondria we used was efficient to analyze (4) . P/O ratio was 2.5-4.0 in ND mice, and these values were consistent with a previous report (2) . P/O ratio is theoretically 2.5 (4), and we could not clarify why the P/O ratio was high. State 3 respiration and RCI were significantly decreased in HFD compared with ND mice without any changes in state 4 respiration in the presence of both glutamate-malate (Fig. 5B) and carnitine palmitate-malate (Fig. 5C ) as substrate. P/O ratio did not differ between groups (Fig. 5, B and C) . HFDϩOLM mice had significantly improved state 3 respiration and RCI compared with the HFD mice.
Red/green fluorescence ratio in JC-1 was 2.59 Ϯ 0.17 in mitochondria from ND mice, indicating that membrane integrity was preserved in the isolated mitochondria we used in the present study. Furthermore, it was comparable among ND, NDϩOLM, HFD, and HFDϩOLM mice (2.59 Ϯ 0.17, 2.51 Ϯ 0.17, 2.26 Ϯ 0.17, and 2.68 Ϯ 0.14, P ϭ not significant).
Fiber type and cell cross-sectional area in skeletal muscle. Figure 6A shows representative images of staining for HE, myosin ATPase, SDH, and COX. There was no difference in muscle cell cross-sectional area among the four groups (Fig. 6 , A and B). Fiber type staining revealed that type I was decreased in HFD mice compared with ND mice, and increased in HFDϩOLM mice (Fig. 6A) . Type IIb was not altered in all groups. Summary data for myosin ATPase staining showed that type I was significantly decreased in HFD mice compared with ND mice, and increased in HFDϩOLM mice (Fig. 6C) . Type IIa and IIb were not altered in all groups (Fig. 6C) . Gene expressions of MYH2 and MYH7 were significantly decreased in HFD mice compared with ND mice, and increased in HFDϩOLM mice (data not shown). MYH1 and MYH4 were not altered in all groups (data not shown).
Gene expressions regulating mitochondrial function and biogenesis. In agreement with the change in O 2 consumption, gene expression of ndufa2, uqcrc2, cytochrome c, and cox4i1 was significantly decreased in hindlimb skeletal muscle from HFD compared with ND mice (Fig. 7A) . Gene expression of citrate synthase, IDH2, and MDH2 was also significantly decreased in HFD compared with ND mice (Fig. 7B) . Gene expression of ndufa2, uqucr2, cox4i1, citrate synthase IDH2, and MDH2 was significantly improved in HFDϩOLM compared with HFD mice (Fig. 7) . In contrast, gene expression of PGC-1␣, sirt-1, Tfam, and NRF-1 and protein expression of p-AMPK/AMPK were not altered in HFD mice (Fig. 8, A and B) .
Enzyme activity and gene expression regulating glucose and FFA metabolism, and metabolic by-product. PDH activity and gene expression of PKm2 and LDHb were comparable among the four groups (Fig. 9A) . Serum ␤-OHB intended to be increased in HFD mice compared with ND mice, and decreased in HFDϩOLM mice (Fig. 9B) . CPT-1b was decreased in HFD mice compared with ND mice, and increased in HFDϩOLM mice (Fig. 9C) . Gene expression of FABP3, CD36 (FAT/CD36), and FATP1 was comparable among the four groups (Fig. 9C) .
O 2 Ϫ production, NAD(P)H oxidase activity, oxidative stress, and gene expression of NAD(P)H oxidase subunits and antioxidant capacity in skeletal muscle. O 2 Ϫ production and NAD(P)H oxidase activity measured by lucigenin chemiluminescence were significantly increased in limb skeletal muscle from HFD compared with ND mice, and their changes were inhibited by OLM (Fig. 10, A and B) . Increased O 2 Ϫ production in HFD mice was inhibited in the presence of apocynin, and it was not affected in the presence of other inhibitors (Fig. 10C) . Chemiluminescence signals in the homogenates isolated from skeletal muscle in HFD mice were enhanced by the addition of NAD(P)H, and were not affected by other substrates (Fig. 10D) . Therefore, these results suggested that the increased O 2 Ϫ production in HFD mice was due to increased NAD(P)H oxidase activity, but not mitochondria, xanthine oxidase activity, or nitric oxide synthase activity. TBARS in serum and skeletal muscle were increased in HFD mice compared with ND mice, and were significantly inhibited by OLM (Fig. 10E) . Gene expression of p22 phox , p47 phox , p67 phox , and p40 phox was significantly in- creased in HFD mice compared with ND mice, and improved in HFDϩOLM mice (Fig. 10F) . Gene expression of NOX2 tended to be increased in HFD mice compared with ND mice, which, however, did not reach statistical significance (P ϭ 0.095), and was significantly improved in HFDϩOLM mice compared with HFD mice.
SOD, catalase, and GPX activities and gene expressions of SOD1, SOD2, Cat, and GPX were comparable between groups (Fig. 11) .
DISCUSSION
HFD-induced type 2 diabetic mice had lowered exercise capacity, a decreased peak V O 2 , impaired mitochondrial respiratory activities, decreased oxidative fiber type, decreased gene expressions of the mitochondrial complex and citrate synthase, and enhanced oxidative stress in skeletal muscle, all of which were significantly ameliorated by chronic treatment of HFD mice with OLM. Therefore, AT1R signaling may be at least in part involved in the lowered exercise capacity and mitochondrial dysfunction of HFD-induced type 2 diabetes.
Activation of RAS in HFD-induced diabetes. The activation of local as well as systemic RAS has been shown to be involved in the development of type 2 diabetes. In a metaanalysis of clinical trials, the inhibitors of RAS have been reported to reduce the new onset of diabetes mellitus (1) . In the experimental studies, the treatment with AT1R blocker improved insulin resistance in HFD mice and fructose-fed rats (6, 10, 25) . A recent study reported that the expression of AT1R was increased in adipose tissue from HFD mice, which was associated with systemic insulin resistance (6) . Furthermore, the activation of RAS, especially local RAS, is also associated with the development of diabetic complications (15, 19, 27) . In the present study, serum ACE activity, plasma ANG II level, and serum aldosterone level were increased in HFD mice (Fig.  2) . Gene expression of RAS components and AT1R protein level in skeletal muscle did not differ between ND and HFD mice (Fig. 3) . In contrast, G␣q protein level in skeletal muscle was increased in HFD mice (Fig. 3) . Therefore, these data suggested that systemic RAS and downstream signaling of AT1R in the skeletal muscle were activated in HFD mice.
Beneficial effects of OLM on exercise capacity and mitochondrial function. The most significant finding of the present study is that chronic administration of OLM into HFD mice ameliorated the decrease in exercise capacity (Fig. 4 and Table  2 ), ameliorated the impaired mitochondrial respiratory function (Fig. 5) , improved the decreased oxidative fiber (Fig. 6) , and improved the decreased gene expression of mitochondrial complex and tricarboxylic acid (TCA) cycle rate-limiting enzyme in the skeletal muscle (Fig. 7) . In contrast, OLM did not affect those in ND mice. These results suggested that the activated RAS might be at least in part involved in the lowered exercise capacity in this model. Feng et al. (9) also reported that chronic administration of telmisartan into normal mice enhanced running endurance. However, the enhancement of exercise capacity by telmisartan was associated with the decrease in body weight gain and was considered to be due to the activation of peroxisome proliferator activated receptor ␦ rather than the inhibition of AT1R in their study. Candesartan has been also demonstrated to improve exercise capacity in patients with hypertension, which, however, was accompanied with the reduction of blood pressure (8) . Importantly, the beneficial effects of OLM on exercise capacity shown in the present study were independent of blood pressure, body weight, or glucose metabolism (Table 1 and Fig. 1 ). However, we could not completely exclude the changes in substrate availability by OLM, because we did not directly measure substrate flux.
Lowered exercise capacity is generally believed to be due to abnormalities in energy metabolism in skeletal muscle (16, 26, 41, 42) , which depends on mitochondrial function. Therefore, exercise capacity is closely linked to mitochondrial function in the skeletal muscle. We previously reported that exercise capacity was lowered and mitochondrial function was impaired in ANG II-infused mice, which was associated with enhanced oxidative stress (14) . In addition, ANG II has been demonstrated to directly impair mitochondrial function in cultured skeletal muscle cells through the increased production of O 2 Ϫ (21). Therefore, based on these our present data also confirmed that AT1R signaling was involved in the lowered exercise capacity and mitochondrial dysfunction in HFD mice.
Mitochondrial function and mitochondrial biogenesis in HFD mice. We observed impaired mitochondrial function including mitochondrial respiratory activity, TCA cycle, and substrate metabolism in HFD mice (Figs. 5, 7, 9 ). In contrast, there was no difference in gene expressions regulating mitochondrial biogenesis (Fig. 8) . PGC-1␣ is a key factor regulating mitochondrial function as well as fiber type and mitochondrial density. We previously reported that mitochondrial density was decreased in HFD mice compared with ND mice, which was ameliorated by an inhibition of oxidative stress (41) . Furthermore, this change in mitochondrial density was consistent with the changes in mitochondrial function and constituents, which agreed with previous reports (7, 13) . It has been reported that mitochondrial function and content are impaired through the decreased expression of PGC-1␣ in C2C12 cells with ANG II and in the skeletal muscle from ANG II-infused mice (21) . The differences with our data might be due to the difference in ANG II concentration in animal models (HFD mice with intrinsic RAS activation vs. mice with extrinsic ANG II infusion).
Mechanisms for activation of NAD(P)H oxidase in skeletal muscle. The present study demonstrated that oxidative stress was enhanced in skeletal muscle from HFD mice (Fig. 10) . It Ϫ production (C; n ϭ 6 for each group) and effects of various substrates on enzymatic activities (D; n ϭ 6 for each group) in skeletal muscle from HFD are shown. Thiobarbituric acid reactive substance (TBARS) in serum and skeletal muscle (E, n ϭ 8 for each group), quantitative analysis of gene expressions of NAD(P)H oxidase subunits mRNA (p22 phox , Nox 2, p47 phox , p67 phox , p40 phox , and rac-1, n ϭ 8 for each group; F) in skeletal muscle obtained from 4 groups of ND, NDϩOLM, HFD, and HFDϩOLM mice. Data are means Ϯ SE. RLU, relative light unit; L-NAME, nitro-L-arginine methyl ester. *P Ͻ 0.05 vs. ND; †P Ͻ 0.05 vs. HFD; ‡P Ͻ 0.05 vs. absence of inhibitor or substrate.
has also been confirmed in patients with type 2 diabetes (28) and in an animal model of diabetes (38) . Oxidative stress in type 2 diabetes has been shown to be attributable to O 2 Ϫ derived from NAD(P)H oxidase (31) . Various stimulations, such as high glucose, insulin, and free fatty acids, have been demonstrated to activate NAD(P)H oxidase (39) . In the present study, OLM inhibited NAD(P)H oxidase activity and O 2 Ϫ production to ND mice levels (Fig. 10) . However, it did not affect blood glucose metabolism, plasma insulin, and NEFA (Table 1 and Fig. 1) . Therefore, these factors did not participate in the activation of NAD(P)H oxidase in HFD-fed diabetic mice.
ANG II is an important stimulus for NAD(P)H oxidases in a variety of cells, including vascular smooth muscle cells (12) , endothelial cells (18) , and myocardial cells (32) . The activation of AT1R has been reported to lead to c-Src-dependent phosphorylation of p47 phox and the subsequent translocation of p47 phox to the membrane (35, 36) . In addition to the activation of NAD(P)H oxidase, ANG II also increases gene expression of NAD(P)H oxidase subunits. In a cell culture study, ANG II has been shown to upregulate gene expression of the NAD(P)H oxidase subunits Nox2, p47 phox , p22 phox , p67 phox , and p40 phox in smooth muscle cells (34) . Our data also showed that the gene expression of NAD(P)H oxidase subunits as well as NAD(P)H oxidase activity were increased in skeletal muscle from HFD-fed mice, and OLM completely inhibited this upregulation (Fig. 10) .
Limitations. There are several limitations that should be acknowledged in the present study. First, we used only OLM and did not examine the effects of other AT1R blockers. Therefore, we could not comment whether our findings are specific for OLM or other AT1R blockers and could provide similar beneficial effects. Second, OLM did not affect body weight, glucose metabolism, and plasma insulin in HFD-fed mice ( Fig. 1 and Table 1 ). In contrast, previous animal studies have shown that AT1R blocker decreases body weight and plasma insulin and improves glucose metabolism in diabetic models (6, 10, 17, 25) . These differences might be due to differences in the species (mice vs. rats) and model (HFD vs. fructose-fed vs. type 2 diabetic KKAy mice) examined, AT1R used (OLM vs. telmisartan vs. valsartan), and the treatment duration (8 wk vs. 12 wk). Finally, OLM completely improved mitochondrial respiration (Fig. 5 ) and the decreased oxidative fiber (Fig. 6) , as well as gene expression levels of oxidative phosphorylation, ratelimiting enzyme of the TCA cycle (Fig. 7) , and inhibited oxidative stress (Fig. 10) , whereas it partially increased exercise capacity in HFD mice (Fig. 4) . These results are consistent with our previous data with apocynin, an inhibitor of NAD(P)H oxidase activation (41) . This implies that other mechanisms can also be involved in the lowered exercise capacity in HFD mice. In particular, we could not completely exclude the influence of the increase in body weight and decrease in physical activity on the exercise capacity in HFD mice. How- ever, these did not affect the favorable effects of OLM on the exercise capacity in HFD mice. Clinical implication. A drastic increase of patients with type 2 diabetes is a growing medical as well as public health problem in industrialized countries. The lowered exercise capacity in type 2 diabetes could lead to further deterioration of disease by preventing the proper exercise therapy. Our present data showed that the pharmacological treatment to inhibit RAS improved exercise capacity. AT1R blocker is recommended to prevent diabetic complications (3) . Therefore, the present study findings may further draw attention to the early and intensive treatment of type 2 diabetes by using AT1R blocker.
CONCLUSION
OLM ameliorated the lowered exercise capacity in HFDinduced diabetic mice via the improvement of impaired mitochondrial function and attenuation of oxidative stress in the skeletal muscle. Treatment with AT1R blocker may attenuate progression in decreased exercise capacity in patients with high risk of type 2 diabetes mellitus.
